Among the genes differentially expressed in IgM U-CLL cells, GSEA identified several significantly enriched gene sets indicating activation of distinct signaling pathways compared with IgM and IgG M-CLL cells, particularly BcR, NF-κB, and MAPK-ERK signaling pathways. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.